高雄醫師會誌102期-醫學專欄~曾秉濤-文獻導讀:以統合分析來探討omega-3對焦慮症狀的影響
- 2. PUFA
(Post-traumatic stress disorder, PTSD) (4)
(anxiety disorder) (5)
omega-3
omega-3
omega-3
(6-8)
vs.
(placebo
effect)
JAMA Network Open
placebo
effect
19
omega-3
(
Alzheimer
)
19
omega-3
3
(placebo)
3
16
16
omega-3
- 5. ( 5FU/
LV, oxaliplantin, irrinotecan )
( anti-VEGF monoclonal antibody,
anti-EGFR monoclonal antibody)
regorafenib
VEGFR-1,
-3 RAF BRAF
regorafenib
28 21
160mg
regorafenib
regorafenib FOLFIRI
73 100 4
(pT3N1M0)
FOLFOX
101 9
101 10 102 5
FOLFIRI
capecitabine 102 5 103
5 5
- 6. 103 11
104 9 FOLFIRI
Bevacizumab 12
105 6 FOLFIRI
regorafenib
29 29
regorafenib
CORRECT CONCUR
regorafenib
(overall
survival) 23 45%
(progression free
survival) 51 69%
regorafenib (disease
control rate) 41 51.5%
Schmieder
regorafenib irinotecan
regorafenib
irinotecan
Schultheis
regorafenib FOLFIRI
regorafenib FOLFOX
regorafenib
FOLFIRI
UGT1A1 irinotecan
regorafenib
UGT1A1
TA6/TA6 TA6/TA7 irinotecan
180 mg/m2